Weekly Tactical Pick – Suven Pharma
Technical prowess and healthy balance sheet make Suven Pharma a strong thematic play
June 21, 2021 / 12:53 AM IST
Eris Lifesciences Ltd.
PRO Only Highlights
Quarterly performance largely backed by improved realisations
Medium-term triggers China plus and protectionist measures for tyre industry
Valuations not inexpensive; but improved medium-term outlook
The latest Federal Reserve meet has projected an evolving macro scenario where inflation data can no longer be ignored as just a transitory outcome of supply bottlenecks. Fed Chair Jerome Powell has observed that, backed by household savings during the pandemic, shifts in demand can be large and rapid, leading to a wide gap between demand and supply in a few pockets. This may cause inflation to be persistently higher in the future.
Also read: US Fed meet ratchets up...